Abstract
The pathophysiology of type 2 diabetes includes two apparently distinct defects i.e. impaired insulin action at the level of muscle, fat and liver, and failure in β-cells secretory capacity. Insulin action is mediated by the insulin receptor, (IR) a member of the receptor tyrosine kinase family also including the type 1 Insulin-like Growth Factor I (IGF-I) receptor (IGF-IR) and the orphan receptor Insulin Receptor-Related Receptor (IRR). IR exists in two functionally distinct isoforms differing by the absence (Ex11-) or presence (Ex11+) of a 12 amino acid sequence in the COOH-terminus of the α-subunit due to alternative splicing of exon 11. In addition to forming homodimers, IR, IGF-IR and IRR can form hybrid receptors. IR / IGF-IR hybrids bind IGF-I, but not insulin, with high affinity, and function as IGF-IR homoreceptors rather than IR homoreceptors. The function of IRR is unknown and it does not transduce signals through IR / IRR hybrids. The generation of genetically engineered knockout mice with total or tissue -specific lack of IR has been instrumental in dissecting the pathophysiological role of IR not only in classical target tissues, such as muscle and liver, but also in non-classical target tissues, such as brain and pancreatic β-cells. Some, but not all, studies have reported that expression of the low-affinity Ex11+ isoform is increased in target tissues from type 2 diabetics, thus contributing to insulin resistance. There is evidence that abundance of IR / IGF-IR hybrid receptors is increased in insulin target tissues, where they might affect insulin sensitivity by sequestering IR in a less insulin-responsive form. This review will focus on the structural and functional heterogeneity of IR and related receptors, and will discuss the studies in knockout mice lacking IR. Finally, studies addressing the potential role of IR variant forms in the development of conditions of insulin resistance, such as obesity and type 2 diabetes mellitus will be reviewed.
Keywords: Type 2 diabetes,, obesity,, insulin resistance,, insulin receptor isoforms,, IGF-I receptor,, hybrid receptor.
Current Genomics
Title: Role of the Insulin Receptor Variant Forms in Human Metabolic Disorders
Volume: 4 Issue: 4
Author(s): Giorgio Sesti
Affiliation:
Keywords: Type 2 diabetes,, obesity,, insulin resistance,, insulin receptor isoforms,, IGF-I receptor,, hybrid receptor.
Abstract: The pathophysiology of type 2 diabetes includes two apparently distinct defects i.e. impaired insulin action at the level of muscle, fat and liver, and failure in β-cells secretory capacity. Insulin action is mediated by the insulin receptor, (IR) a member of the receptor tyrosine kinase family also including the type 1 Insulin-like Growth Factor I (IGF-I) receptor (IGF-IR) and the orphan receptor Insulin Receptor-Related Receptor (IRR). IR exists in two functionally distinct isoforms differing by the absence (Ex11-) or presence (Ex11+) of a 12 amino acid sequence in the COOH-terminus of the α-subunit due to alternative splicing of exon 11. In addition to forming homodimers, IR, IGF-IR and IRR can form hybrid receptors. IR / IGF-IR hybrids bind IGF-I, but not insulin, with high affinity, and function as IGF-IR homoreceptors rather than IR homoreceptors. The function of IRR is unknown and it does not transduce signals through IR / IRR hybrids. The generation of genetically engineered knockout mice with total or tissue -specific lack of IR has been instrumental in dissecting the pathophysiological role of IR not only in classical target tissues, such as muscle and liver, but also in non-classical target tissues, such as brain and pancreatic β-cells. Some, but not all, studies have reported that expression of the low-affinity Ex11+ isoform is increased in target tissues from type 2 diabetics, thus contributing to insulin resistance. There is evidence that abundance of IR / IGF-IR hybrid receptors is increased in insulin target tissues, where they might affect insulin sensitivity by sequestering IR in a less insulin-responsive form. This review will focus on the structural and functional heterogeneity of IR and related receptors, and will discuss the studies in knockout mice lacking IR. Finally, studies addressing the potential role of IR variant forms in the development of conditions of insulin resistance, such as obesity and type 2 diabetes mellitus will be reviewed.
Export Options
About this article
Cite this article as:
Sesti Giorgio, Role of the Insulin Receptor Variant Forms in Human Metabolic Disorders, Current Genomics 2003; 4 (4) . https://dx.doi.org/10.2174/1389202033490376
DOI https://dx.doi.org/10.2174/1389202033490376 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Prognostic Implications of Genetics in Cardiovascular Disease
Current Pharmacogenomics Mitochondria: A Novel Therapeutic Target in Diabetic Nephropathy
Current Medicinal Chemistry Menin, Histone H3 Methyltransferases, and Regulation of Cell Proliferation: Current Knowledge and Perspective
Current Molecular Medicine Oxytocin as a Potential Adjuvant Against COVID-19 Infection
Endocrine, Metabolic & Immune Disorders - Drug Targets PDE4D Gene in the STRK1 Region on 5q12: Susceptibility Gene for Ischemic Stroke
Current Medicinal Chemistry Regular Physical Activity and Vascular Aging
Current Pharmaceutical Design Renal Protective Effect of Metabolic Therapy in Patients with Coronary Artery Disease and Diabetes: From Bench to Bed Side
Current Pharmaceutical Design A Review of the Evidence for a Neuroendocrine Link Between Stress, Depression and Diabetes Mellitus
Current Diabetes Reviews Rosuvastatin and Diabetes: When the Evidences Talk
Cardiovascular & Hematological Agents in Medicinal Chemistry Vascular Endothelial Growth Factor in Central Nervous System Injuries – A Vascular Growth Factor Getting Nervous?
Current Neurovascular Research Atopic Dermatitis in the Elderly
Inflammation & Allergy - Drug Targets (Discontinued) Childhood Alopecia Areata: An Overview of Treatment and Recent Patents
Recent Patents on Inflammation & Allergy Drug Discovery Interaction of Drug or Food with Drug Transporters in Intestine and Liver
Current Drug Metabolism Modelling of Aldose Reductase Inhibitory Activity of Pyrrol-1-yl-acetic Acid Derivatives by Means of Multivariate Statistics
Medicinal Chemistry Assessing Coronary Blood Flow Physiology in the Cardiac Catheterisation Laboratory
Current Cardiology Reviews Blood Pressure and the Risk of Dementia: A Dose-Response Meta-Analysis of Prospective Studies
Current Neurovascular Research Endothelial Extracellular Vesicles Produced by Senescent Cells: Pathophysiological Role in the Cardiovascular Disease Associated with all Types of Diabetes Mellitus
Current Vascular Pharmacology HIV-Antigens Charged on Phosphorus Dendrimers as Tools for Tolerogenic Dendritic Cells-Based Immunotherapy
Current Medicinal Chemistry L-Arginine in the Prevention and Treatment of Cardiovascular Disease: From Basic to Clinical Research Studies
Vascular Disease Prevention (Discontinued) Myocardial Infarction with and without ST-segment Elevation: a Contemporary Reappraisal of Similarities and Differences
Current Cardiology Reviews